pre-seed
Stage
3
Investors
About
Abingdon Health develops, manufactures, and supports lateral flow immunoassay rapid diagnostic tests for healthcare and other industries, offering end-to-end CDMO services including development, scale-up, manufacturing, regulatory consultancy, and commercial support.
Explore Abingdon Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.